Global Major Depressive Disorder (MDD) Therapeutics Market Is Declined at a CAGR of 4% to $7.4 Billion by 2017; Finds New Report
The global market for Major Depressive Disorder (MDD) therapeutics was valued at $8.7 billion in 2013, and several key patent expiries will cause it to decline at a negative Compound Annual Growth Rate (CAGR) of 4% to $7.4 billion by 2017.
View full press release